{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:18:49Z","timestamp":1789607929004,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ogc.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T23:04:07Z","timestamp":1620428647000},"page":"419-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recurrence Risk of Fetal Growth Restriction"],"prefix":"10.1016","volume":"48","author":[{"given":"Nathan R.","family":"Blue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ogc.2021.03.002_bib1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199904223401603","article-title":"Birth weight in relation to morbidity and mortality among newborn infants","volume":"340","author":"McIntire","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"9390","key":"10.1016\/j.ogc.2021.03.002_bib2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(03)14466-2","article-title":"Cerebral palsy and intrauterine growth in single births: European collaborative study","volume":"362","author":"Jarvis","year":"2003","journal-title":"Lancet."},{"issue":"12","key":"10.1016\/j.ogc.2021.03.002_bib3","doi-asserted-by":"crossref","first-page":"e1002717","DOI":"10.1371\/journal.pmed.1002717","article-title":"Small for gestational age and risk of childhood mortality: A Swedish population study","volume":"15","author":"Ludvigsson","year":"2018","journal-title":"PLOS Med"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12884-019-2358-8","article-title":"Deceleration of fetal growth rate as alternative predictor for childhood outcomes: a birth cohort study","volume":"19","author":"Broere-Brown","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib5","doi-asserted-by":"crossref","first-page":"S869","DOI":"10.1016\/j.ajog.2017.12.012","article-title":"Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease","volume":"218","author":"Crispi","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib6","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2214-109X(13)70006-8","article-title":"National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Glob Health"},{"issue":"13\u201314","key":"10.1016\/j.ogc.2021.03.002_bib7","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/jocn.14219","article-title":"Examining the content and moderators of women's fears for giving birth: A meta-synthesis","volume":"27","author":"Sheen","year":"2018","journal-title":"J\u00a0Clin Nurs"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib8","doi-asserted-by":"crossref","first-page":"374.e1-6","DOI":"10.1016\/j.ajog.2013.01.045","article-title":"Recurrence of small-for-gestational-age pregnancy: analysis of first and subsequent singleton pregnancies in The Netherlands","volume":"208","author":"Voskamp","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ogc.2021.03.002_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/14767050902740207","article-title":"Recurrence of fetal growth restriction in singleton and twin gestations","volume":"22","author":"Ananth","year":"2009","journal-title":"J\u00a0Maternal-Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.ogc.2021.03.002_bib10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/1471-0528.12628","article-title":"Differences in risk factors for incident and recurrent small-for-gestational-age birthweight: a hospital-based cohort study","volume":"121","author":"Hinkle","year":"2014","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0029-1223268","article-title":"Risk factors for recurrent small-for-gestational-age birth","volume":"27","author":"Okah","year":"2010","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib12","doi-asserted-by":"crossref","first-page":"624.e1-7","DOI":"10.1016\/j.ajog.2015.01.009","article-title":"Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis","volume":"212","author":"van Oostwaard","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00404-019-05339-x","article-title":"Recurrent intrauterine growth restriction: characteristic placental histopathological features and association with prenatal vascular Doppler","volume":"300","author":"Rotshenker-Olshinka","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"10.1016\/j.ogc.2021.03.002_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ogc.2019.10.008","article-title":"The placental basis of fetal growth restriction","volume":"47","author":"Zur","year":"2020","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"7","key":"10.1016\/j.ogc.2021.03.002_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/apm.12796","article-title":"Placental pathologic lesions with a significant recurrence risk - what not to miss!","volume":"126","author":"Chen","year":"2018","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2006-947164","article-title":"Advanced maternal age is an independent risk factor for intrauterine growth restriction","volume":"23","author":"Odibo","year":"2006","journal-title":"Am J Perinatol"},{"issue":"10","key":"10.1016\/j.ogc.2021.03.002_bib18","doi-asserted-by":"crossref","first-page":"e0186287","DOI":"10.1371\/journal.pone.0186287","article-title":"Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis","volume":"12","author":"Lean","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/01443615.2017.1290057","article-title":"Risk of recurrence of small-for-gestational-age foetus after first pregnancy","volume":"37","author":"Manzanares","year":"2017","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.ogc.2021.03.002_bib20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jamainternmed.2018.4696","article-title":"Association of Short Interpregnancy Interval With Pregnancy Outcomes According to Maternal Age","volume":"178","author":"Schummers","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/AOG.0000000000002358","article-title":"Within-family analysis of interpregnancy interval and adverse birth outcomes","volume":"130","author":"Class","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2021.03.002_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/AOG.0000000000001891","article-title":"Interpregnancy interval and adverse pregnancy outcomes: an analysis of successive pregnancies.","volume":"129","author":"Hanley","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib23","doi-asserted-by":"crossref","first-page":"O73","DOI":"10.1111\/ppe.12506","article-title":"Short interpregnancy interval and poor fetal growth: Evaluating the role of pregnancy intention","volume":"33","author":"Liauw","year":"2019","journal-title":"Paediatric Perinatal Epidemiol"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12884-021-03593-z","article-title":"Impact of nicotine and maternal BMI on fetal birth weight","volume":"21","author":"G\u00fcnther","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"10.1016\/j.ogc.2021.03.002_bib25","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s10995-019-02751-2","article-title":"Smoking cessation and pregnancy: timing of cessation reduces or eliminates the effect on low birth weight","volume":"23","author":"Xaverius","year":"2019","journal-title":"Matern Child Health J"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib26","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/AOG.0000000000004251","article-title":"Fetal Growth Restriction: ACOG Practice Bulletin, Number 227","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM200207043470105","article-title":"Absence of association of thrombophilia polymorphisms with intrauterine growth restriction","volume":"347","author":"Infante-Rivard","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ogc.2021.03.002_bib28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1067\/mob.2003.218","article-title":"Inherited thrombophilias are not increased in \u201cidiopathic\u201d small-for-gestational-age pregnancies","volume":"188","author":"McCowan","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1471-0528.2002.00411.x","article-title":"Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants","volume":"109","author":"Verspyck","year":"2002","journal-title":"BJOG"},{"issue":"20","key":"10.1016\/j.ogc.2021.03.002_bib30","doi-asserted-by":"crossref","first-page":"e15733","DOI":"10.1097\/MD.0000000000015733","article-title":"Pregnancy outcomes in patients with primary antiphospholipid syndrome: A systematic review and meta-analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)."},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2011.02.006","article-title":"The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis","volume":"128","author":"Abou-Nassar","year":"2011","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.ogc.2021.03.002_bib32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1055\/s-0038-1641168","article-title":"Are Anti-\u03b22 glycoprotein 1 antibodies associated with placenta-mediated pregnancy complications? a nested case\u2013control study","volume":"35","author":"Skeith","year":"2018","journal-title":"Am J Perinatol"},{"issue":"3","key":"10.1016\/j.ogc.2021.03.002_bib33","doi-asserted-by":"crossref","first-page":"e0230488","DOI":"10.1371\/journal.pone.0230488","article-title":"Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy","volume":"15","author":"Morikawa","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ogc.2021.03.002_bib34","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s00125-012-2721-z","article-title":"HbA1c and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study","volume":"55","author":"Glinianaia","year":"2012","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib35","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ogc.2021.03.002_bib37","doi-asserted-by":"crossref","first-page":"e1002866","DOI":"10.1371\/journal.pmed.1002866","article-title":"Pregnancy after bariatric surgery and adverse perinatal outcomes: A systematic review and meta-analysis","volume":"16","author":"Akhter","year":"2019","journal-title":"PLOS Med"},{"key":"10.1016\/j.ogc.2021.03.002_bib38","article-title":"A\u00a0matter of timing\u2014pregnancy after bariatric surgery","author":"Heusschen","year":"2021","journal-title":"Obes Surg"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib39","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/AOG.0b013e3181ac0544","article-title":"ACOG practice bulletin no. 105: bariatric surgery and pregnancy","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib40","article-title":"Zinc supplementation for improving pregnancy and infant outcome","author":"Ota","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib41","article-title":"Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes","author":"Buppasiri","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ogc.2021.03.002_bib42","article-title":"Magnesium supplementation in pregnancy","author":"Makrides","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ogc.2021.03.002_bib43","article-title":"Vitamin C supplementation in pregnancy","author":"Rumbold","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib44","article-title":"Vitamin D supplementation for women during pregnancy","author":"De-Regil","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ogc.2021.03.002_bib45","article-title":"Vitamin E supplementation in pregnancy","author":"Rumbold","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/uog.14910","article-title":"Omega-3 supplementation during pregnancy to prevent recurrent intrauterine growth restriction: systematic review and meta-analysis of randomized controlled trials","volume":"46","author":"Saccone","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ogc.2021.03.002_bib47","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1017\/S0007114515001166","article-title":"Maternal iron status in early pregnancy and birth outcomes: insights from the Baby's Vascular health and Iron in Pregnancy study","volume":"113","author":"Alwan","year":"2015","journal-title":"Br J Nutr"},{"issue":"10","key":"10.1016\/j.ogc.2021.03.002_bib48","article-title":"Intermittent oral iron supplementation during pregnancy","author":"Pe\u00f1a-Rosas","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ogc.2021.03.002_bib49","article-title":"Daily oral iron supplementation during pregnancy","author":"Pe\u00f1a-Rosas","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ogc.2021.03.002_bib50","article-title":"Lipid-based nutrient supplements for maternal, birth, and infant developmental outcomes","author":"Das","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ogc.2021.03.002_bib51","article-title":"Multiple-micronutrient supplementation for women during pregnancy","author":"Haider","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"10.1016\/j.ogc.2021.03.002_bib52","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1113\/JP273331","article-title":"Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy","volume":"595","author":"Cottrell","year":"2017","journal-title":"J\u00a0Physiol"},{"issue":"9","key":"10.1016\/j.ogc.2021.03.002_bib53","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3390\/nu12092535","article-title":"Prenatal Amino Acid Supplementation to Improve Fetal Growth: A Systematic Review and Meta-Analysis","volume":"12","author":"Terstappen","year":"2020","journal-title":"Nutrients."},{"issue":"13","key":"10.1016\/j.ogc.2021.03.002_bib54","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1471-0528.2010.02737.x","article-title":"Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study","volume":"117","author":"McCowan","year":"2010","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib55","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/14034940600717688","article-title":"Association between fruit and vegetable consumption and birth weight: A prospective study among 43,585 Danish women","volume":"34","author":"Mikkelsen","year":"2006","journal-title":"Scand J Public Health"},{"issue":"3","key":"10.1016\/j.ogc.2021.03.002_bib56","first-page":"561","article-title":"Vegetable but not fruit intake during pregnancy is associated with newborn anthropometric measures","volume":"139","author":"Ram\u00f3","year":"2009","journal-title":"J\u00a0Nutr"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib57","doi-asserted-by":"crossref","first-page":"e1003491","DOI":"10.1371\/journal.pmed.1003491","article-title":"Associations of maternal dietary inflammatory potential and quality with offspring birth outcomes: An individual participant data pooled analysis of 7 European cohorts in the ALPHABET consortium","volume":"18","author":"Chen","year":"2021","journal-title":"PLOS Med"},{"issue":"8","key":"10.1016\/j.ogc.2021.03.002_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020424","article-title":"Maternal seafood intake and the risk of small for gestational age newborns: a case\u2013control study in Spanish women","volume":"8","author":"Amezcua-Prieto","year":"2018","journal-title":"BMJ Open."},{"issue":"Suppl 3","key":"10.1016\/j.ogc.2021.03.002_bib59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/nutrit\/nuv053","article-title":"Pregnancy diet and associated outcomes in the Avon Longitudinal Study of Parents and Children","volume":"73","author":"Emmett","year":"2015","journal-title":"Nutr Rev"},{"issue":"nov03 2","key":"10.1016\/j.ogc.2021.03.002_bib60","doi-asserted-by":"crossref","first-page":"a2332","DOI":"10.1136\/bmj.a2332","article-title":"Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study","volume":"337","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib61","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3945\/ajcn.2009.28792","article-title":"Maternal caffeine intake from coffee and tea, fetal growth, and the risks of adverse birth outcomes: the Generation R Study","volume":"91","author":"Bakker","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib62","article-title":"Antenatal dietary education and supplementation to increase energy and protein intake","author":"Ota","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0705907","article-title":"Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action","volume":"143","author":"Taubert","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ogc.2021.03.002_bib64","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0006-291X(03)01504-3","article-title":"Heme oxygenase-1 induction may explain the antioxidant profile of aspirin","volume":"308","author":"Grosser","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16\u00a0weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib66","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2021.03.002_bib67","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ogc.2021.03.002_bib68","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ogc.2021.03.002_bib69","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and Management of Fetal Growth Restriction","volume":"223","author":"Martins","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2021.03.002_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2015.06.021","article-title":"Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians","volume":"193","author":"Vayssi\u00e8re","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ogc.2021.03.002_bib71","unstructured":"Stillbirth PSoAaNZaCoRE. Position statement: detection and management of fetal growth restriction in singleton pregnancies. Brisbane, Australia: Centre of Research Excellence in Stillbirth; 2019."},{"issue":"8","key":"10.1016\/j.ogc.2021.03.002_bib72","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1701-2163(15)30865-3","article-title":"Intrauterine Growth Restriction: Screening, Diagnosis, and Management","volume":"35","author":"Lausman","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ogc.2021.03.002_bib73","first-page":"507151","article-title":"Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib74","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/j.thromres.2009.11.030","article-title":"Low-molecular-weight heparin inhibition in classical complement activaton pathway during pregnancy","volume":"125","author":"Oberkersch","year":"2010","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib75","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ajog.2004.05.014","article-title":"Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in\u00a0vitro","volume":"191","author":"Bose","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in\u00a0vitro: Implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib77","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.116.08298","article-title":"Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women at High Risk of Preeclampsia","volume":"69","author":"McLaughlin","year":"2017","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib78","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/AOG.0b013e31821b5384","article-title":"Angiogenic response of placental villi to heparin","volume":"117","author":"Sobel","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.placenta.2014.12.008","article-title":"Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor","volume":"36","author":"Yinon","year":"2015","journal-title":"Placenta."},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib80","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"De Vries","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9955","key":"10.1016\/j.ogc.2021.03.002_bib82","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet."},{"issue":"14","key":"10.1016\/j.ogc.2021.03.002_bib83","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial","volume":"119","author":"Martinelli","year":"2012","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib84","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","article-title":"Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial","volume":"128","author":"Haddad","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"02","key":"10.1016\/j.ogc.2021.03.002_bib85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost"},{"issue":"17","key":"10.1016\/j.ogc.2021.03.002_bib86","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ogc.2021.03.002_bib87","doi-asserted-by":"crossref","first-page":"296.e1-e4","DOI":"10.1016\/j.ajog.2017.01.014","article-title":"Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial","volume":"216","author":"Groom","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib88","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2013-01-478958","article-title":"Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications","volume":"123","author":"Rodger","year":"2014","journal-title":"Blood."},{"issue":"10060","key":"10.1016\/j.ogc.2021.03.002_bib89","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet."},{"issue":"7198","key":"10.1016\/j.ogc.2021.03.002_bib90","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature06951","article-title":"Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia","volume":"453","author":"Kanasaki","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib91","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.111.186270","article-title":"Sildenafil Citrate Rescues Fetal Growth in the Catechol- O -methyl transferase knockout mouse model","volume":"59","author":"Stanley","year":"2012","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.ogc.2021.03.002_bib92","doi-asserted-by":"crossref","first-page":"e77748","DOI":"10.1371\/journal.pone.0077748","article-title":"Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype","volume":"8","author":"Dilworth","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ogc.2021.03.002_bib93","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/HYPERTENSIONAHA.116.07662","article-title":"Maternal administration of sildenafil citrate alters fetal and placental growth and fetal\u2013placental vascular resistance in the growth-restricted ovine fetus","volume":"68","author":"Oyston","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib94","doi-asserted-by":"crossref","first-page":"102.e1-7","DOI":"10.1016\/j.ajog.2008.08.029","article-title":"The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus","volume":"200","author":"Miller","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"06","key":"10.1016\/j.ogc.2021.03.002_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0032-1304823","article-title":"Effects of Sildenafil in N\u03c9-Nitro-l-Arginine Methyl Ester-Induced Intrauterine Growth Restriction in a Rat Model","volume":"29","author":"Nassar","year":"2012","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib96","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.117.09690","article-title":"Sildenafil During Pregnancy","volume":"70","author":"Paauw","year":"2017","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ogc.2021.03.002_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219732","article-title":"The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis","volume":"14","author":"Ferreira","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ogc.2021.03.002_bib98","doi-asserted-by":"crossref","first-page":"e205323","DOI":"10.1001\/jamanetworkopen.2020.5323","article-title":"Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction","volume":"3","author":"Pels","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.ogc.2021.03.002_bib100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/1471-0528.15658","article-title":"STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction","volume":"126","author":"Groom","year":"2019","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2352-4642(17)30173-6","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","volume":"2","author":"Sharp","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"17","key":"10.1016\/j.ogc.2021.03.002_bib102","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2217\/nnm-2016-0234","article-title":"Could peptide-decorated nanoparticles provide an improved approach for treating pregnancy complications?","volume":"11","author":"Harris","year":"2016","journal-title":"Nanomedicine (Lond)"},{"issue":"6892","key":"10.1016\/j.ogc.2021.03.002_bib103","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nature00819","article-title":"Placental-specific IGF-II is a major modulator of placental and fetal growth","volume":"417","author":"Const\u00e2ncia","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib104","doi-asserted-by":"crossref","first-page":"e1600349","DOI":"10.1126\/sciadv.1600349","article-title":"Tumor-homing peptides as tools for targeted delivery of payloads to the placenta","volume":"2","author":"King","year":"2016","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.ogc.2021.03.002_bib105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1095\/biolreprod.104.033985","article-title":"Uterine artery remodeling and reproductive performance are impaired in endothelial nitric oxide synthase-deficient mice","volume":"72","author":"van der Heijden","year":"2005","journal-title":"Biol Reprod"},{"issue":"1","key":"10.1016\/j.ogc.2021.03.002_bib106","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1038\/s41598-017-06300-1","article-title":"Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development","volume":"7","author":"Phillips","year":"2017","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.ogc.2021.03.002_bib107","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.7150\/thno.19678","article-title":"Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy","volume":"7","author":"Cureton","year":"2017","journal-title":"Theranostics."},{"issue":"2","key":"10.1016\/j.ogc.2021.03.002_bib108","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2021.03.002_bib109","unstructured":"Gynaecologists RCoOa. The Investigation and Management of the Small for Gestational Age Fetus2013. Located at: Green-top Guideline."}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854521000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854521000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:19:51Z","timestamp":1760177991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854521000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0889854521000231"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2021.03.002","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence Risk of Fetal Growth Restriction","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}